N-of-One Published in Scientific American

We, at N-of-One are very excited to have been featured in a special edition of Scientific American, "Pathways: The Changing Science, Business and Experience of Health."

Personalized medicine is increasingly being recognized as the next important step forward in the treatment of individual patients, and N-of-One has emerged as a leader in the field.

N-of-One has been called the "glue that ties technology and patient care together."

In cancer care, the use of molecular diagnostics and genomics on a patient's tumor can be the key to choosing effective targeted therapies; however, this level of care is available to very few. N-of-One bridges the gap by providing access to cutting-edge technologies to the patients fighting cancer and to the physicians working to treat them.

Since the company's inception in 2008, N-of-One has had critical impact and important successes in identifying new treatment options for patients and their physicians in multiple countries. With a growing team of leading scientists and healthcare professionals, along with academic and industry collaborators, N-of-One provides a new approach to delivering oncology care that is patient-focused, individualized, data-driven and collaborative.

Being a young, emerging company, we are proud to invite you to read the recent feature within Scientific American. Everyday, N-of-One and our entire team strives to deliver the most innovative, and new treatments to our patients and physicians.

Please enjoy the article!